Category Archives: Uncategorized

Post ASCO Results

Whether it is the impact of the future usage in ALK positive lung cancer in first line of alectinib over the current standard of care or the potential use of DNA Disease repair in advanced BRCA-related breast cancer, many innovations in cancer treatment will be having an impact on the treatment protocols moving forward.

After every major conference, MDoutlook provides valuable insights to our clients on the impact of new data presented. With the 17 ASCO conference behind us, we will be generating syndicated reports in the following therapy areas:

• Bladder
• Breast
• Hematology: AML, CML
• Hepato-Cellular Carcinoma
• Melanoma
• Non-small cell lung cancer
• Prostate
• Renal Cell Carcinoma

If you would like to purchase or receive more details about our post conference syndicated reports, email me at jan.heybroek@mdoutlook.com.

Researching the Impact of Chicago

Did you know that attendees at ASH in 2016 had B-cell Lymphoma1.7x as many patients with B-cell lymphomas as physicians who did not attend? Would you also be surprised to know that their distribution as to the types of B-cell lymphomas seen are remarkably consistent?

Now think about how that knowledge will drive different insights when measuring the impact of your clinical data announcements at conferences.

After every major conference, MDoutlook provides valuable insights to our clients on the impact of new data presented. This year, immediately following the ASCO meeting, we will be producing syndicated reports in the following therapy areas:

• Bladder
• Breast
• Hematology: AML, CML
• Hepato-Cellular Carcinoma
• Melanoma
• Non-small cell lung cancer
• Prostate
• Renal Cell Carcinoma

If you would like to purchase or receive more details about our post conference syndicated reports, email me at jan.heybroek@mdoutlook.com.

There are still a few spots open to include your proprietary questions if you commit before ASCO.

Click Here to sample the full report from the 2016 ASH meeting on NHL B-cell Lymphoma.